Linéa Bonfils’ Post

Honored to share our gastroscopy findings in patients with persistent reflux symptoms following a negative Cytosponge test at the BSG LIVE’23 event organized by the British Society of Gastroenterology (BSG) We report encouraging outcomes using cytosponges in triaging reflux patients, thereby enabling timely access to gastroscopy in those who require it and reducing unnecessary gastroscopy. (Check the link below to review our poster) #bsglive23 #bsg #cytosponge https://lnkd.in/eaMJaM7k

Please join us on January 31 at 2 PM ET for a webinar presented by Jade A. Etter, PA-C, MSPAS, B.S. In “Bridging the Gap Between Conventional and Functional Medicine,” Jade shares how she utilized the GI-MAP™ to heal and achieve remission naturally from Inflammatory Bowel Disease (IBD). Register to learn: -The intersection of conventional and functional medicine testing -What findings on a GI-MAP test warrant further evaluation and diagnostics -How to establish a referral network, and more . #GIMAP #guthealth #functionalmedicinedoctor #IBD

The patient, aged 42 years, presented with a history of right lumbar pain, vomiting, chest pain, and a past medical history of nephrectomy. The doctor recommended an HRCT Chest to confirm the underlying issues. Upon performing the CT scan and dictating the findings, the radiologist reported the following: 1. Cardiomegaly. 2.Atherosclerotic changes, likely due to renal osteodystrophy renal disease changes. 3.Innumerable rounded frothy opacities widely distributed in both lungs, predominantly in the periphery. The largest one measures 2.2 cm in the apical segment of the left upper lobe and 3.1 cm in the apical segment of the right upper lobe. These findings are suggestive of metastatic deposits, likely primary versus nephrectomy. However, a CECT-Abdomen is advised to complete the evaluation of the abdomen.

Our latest activity is tailored for nephrologists, hepatologists, gastroenterologists, hospitalists, and pharmacists focused on enhancing care for patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI). Dive into the latest data, understand how to integrate new treatments into patient care, and get up to speed with streamlined society guidelines. Accredited by MER in collaboration with the Chronic Liver Disease Foundation, this program is a step forward in improving patient outcomes. #ContinuingEducation #HRS_AKI

The Early Sjögrens Syndrome Test Panel is a valuable immunological tool for clinicians to both identify patients earlier, when therapeutic intervention is most effective, and to also identify patient cohorts most at risk of progression to Sjögren’s Syndrome. The application, subject to approval will allow Immco Diagnostics optimise their market access strategy to deliver broader patient access to the Early Sjogren’s Syndrome Test Panel. It is estimated that up to approximately 3 million people in the US have Sjögrens Syndrome, making it one of the most prevalent autoimmune syndromes. Individuals with Sjögrens Syndrome suffer most notably from dry eyes and dry mouths, as well as difficulty swallowing, increased dental cavities, joint pain and swelling, among other ailments. For more information on the application please see the link below:  https://lnkd.in/e-QfHDQC #SjögrensSyndrome #Laboratory #Autoimmune